✦ LIBER ✦

Intravenous Pamidronate as Treatment for Osteoporosis after Heart Transplantation: A Prospective Study

✍ Scribed by M. A. Krieg; C. Seydoux; L. Sandini; J. J. Goy; D. Gillard Berguer; D. Thie´baud; P. Burckhardt

Publisher: Springer-Verlag
Year: 2001
Tongue: English
Weight: 128 KB
Volume: 12
Category: Article
ISSN: 0937-941X
DOI: 10.1007/s001980170142

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of fetuses in a study of intr

Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial

✍ Deborah M. Friedman; Carolina Llanos; Peter M. Izmirly; Brigit Brock; John Byron 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

PHOENIX: A randomized controlled trial o

PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus

✍ Natalie Bzowej; David R. Nelson; Norah A. Terrault; Gregory T. Everson; Lichen L 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 2 views

The efficacy, tolerability, and safety of the prophylactic treatment of hepatitis C virus (HCV) after liver transplantation (LT) with peginterferon alfa-2a and ribavirin are not known. LT recipients with HCV were randomized to peginterferon alfa-2a/ribavirin treatment or observation 10 to 26 weeks p